GH Optimization
Full somatotropic axis support
Targets the growth hormone axis from multiple angles for complete secretagogue research. CJC-1295 (no DAC) provides GHRH-analog pulsatile release, Ipamorelin offers selective ghrelin-receptor activation, and MK677 adds oral GH secretagogue coverage with sustained IGF-1 elevation.
All components ship together with individual COA documentation
How These Work Together
CJC-1295 (no DAC) acts as a GHRH analog, stimulating pulsatile growth hormone release from the pituitary through the GHRH receptor. Ipamorelin selectively activates the ghrelin/GHS receptor for complementary GH release without affecting cortisol or prolactin. MK677 provides oral ghrelin-mimetic activity with sustained IGF-1 elevation over 24 hours. The three compounds activate the somatotropic axis through three distinct receptor mechanisms for comprehensive GH research.
Related Stacks
Healing Protocol
The gold standard tissue repair stack
2 components · Tissue Repair
GLP-1 Dual Agonist
Head-to-head incretin comparison
2 components · Comparative Metabolic
Triple Threat Weight
Three metabolic pathways, one protocol
3 components · Multi-Pathway Weight
Ready to Start This Protocol?
Order the complete GH Optimization stack at $50.03 and save $6.82 versus buying each component individually.